English

PRAECIS PHARMACEUTICALS INC

EDGAR

Quarterly report (10-Q) · filed 2006-11-09

36 filing records in this dataset, filed from 2000-06-07 to 2006-11-09. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2006-09-30 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

-5.77 million USD

2006-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -22129000 USD Source
Operating Cash Flow: -16356000 USD Source

Free cash flow

-5.83 million USD

2006-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -22129000 USD Source
Operating Cash Flow: -16356000 USD Source
Capital Expenditure: 786000 USD Source
Capital Expenditure: 726000 USD Source

Cash and cash equivalents: 40.4 million USD 2006-09-30 Source
Exact value

40370000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

4.49 million USD

2005-10-01 – 2006-09-30

Exact inputs and evidence

Revenue: 7603000 USD · 2005-01-01 – 2005-12-31 Source
Revenue: 3361000 USD · 2005-01-01 – 2005-09-30 Source
Revenue: 171000 USD · 2006-01-01 – 2006-03-31 Source
Revenue: 73000 USD · 2006-04-01 – 2006-06-30 Source
Revenue: 0 USD · 2006-07-01 – 2006-09-30 Source

Net income

-30.2 million USD

2005-10-01 – 2006-09-30

Exact inputs and evidence

Net income: -61183000 USD · 2005-01-01 – 2005-12-31 Source
Net income: -59883000 USD · 2005-01-01 – 2005-09-30 Source
Net income: -7052000 USD · 2006-01-01 – 2006-03-31 Source
Net income: -15073000 USD · 2006-04-01 – 2006-06-30 Source
Net income: -6753000 USD · 2006-07-01 – 2006-09-30 Source

Operating cash flow

-25.7 million USD

2005-10-01 – 2006-09-30

Exact inputs and evidence

Operating cash flow: -37458000 USD · 2005-01-01 – 2005-12-31 Source
Operating cash flow: -33846000 USD · 2005-01-01 – 2005-09-30 Source
Operating cash flow: -9305000 USD · 2006-01-01 – 2006-03-31 Source
Operating cash flow: -16356000 USD · 2006-01-01 – 2006-06-30 Source
Operating cash flow: -9305000 USD · 2006-01-01 – 2006-03-31 Source
Operating cash flow: -22129000 USD · 2006-01-01 – 2006-09-30 Source
Operating cash flow: -16356000 USD · 2006-01-01 – 2006-06-30 Source

Capital expenditure

997 thousand USD

2005-10-01 – 2006-09-30

Exact inputs and evidence

Capital expenditure: 1395000 USD · 2005-01-01 – 2005-12-31 Source
Capital expenditure: 1184000 USD · 2005-01-01 – 2005-09-30 Source
Capital expenditure: 672000 USD · 2006-01-01 – 2006-03-31 Source
Capital expenditure: 726000 USD · 2006-01-01 – 2006-06-30 Source
Capital expenditure: 672000 USD · 2006-01-01 – 2006-03-31 Source
Capital expenditure: 786000 USD · 2006-01-01 – 2006-09-30 Source
Capital expenditure: 726000 USD · 2006-01-01 – 2006-06-30 Source

Free cash flow

-26.7 million USD

2005-10-01 – 2006-09-30

Exact inputs and evidence

Operating cash flow: -37458000 USD · 2005-01-01 – 2005-12-31 Source
Operating cash flow: -33846000 USD · 2005-01-01 – 2005-09-30 Source
Operating cash flow: -9305000 USD · 2006-01-01 – 2006-03-31 Source
Operating cash flow: -16356000 USD · 2006-01-01 – 2006-06-30 Source
Operating cash flow: -9305000 USD · 2006-01-01 – 2006-03-31 Source
Operating cash flow: -22129000 USD · 2006-01-01 – 2006-09-30 Source
Operating cash flow: -16356000 USD · 2006-01-01 – 2006-06-30 Source
Capital expenditure: 1395000 USD · 2005-01-01 – 2005-12-31 Source
Capital expenditure: 1184000 USD · 2005-01-01 – 2005-09-30 Source
Capital expenditure: 672000 USD · 2006-01-01 – 2006-03-31 Source
Capital expenditure: 726000 USD · 2006-01-01 – 2006-06-30 Source
Capital expenditure: 672000 USD · 2006-01-01 – 2006-03-31 Source
Capital expenditure: 786000 USD · 2006-01-01 – 2006-09-30 Source
Capital expenditure: 726000 USD · 2006-01-01 – 2006-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2006-11-09.

Financial data available through: 2005-12-31.

Coverage by financial measure

Revenue: 7 of 11 periods available· newest 2005-12-31
Operating income: 8 of 11 periods available· newest 2005-12-31
Net income: 8 of 11 periods available· newest 2005-12-31
Operating cash flow: 8 of 11 periods available· newest 2005-12-31
Capital expenditure: 8 of 11 periods available· newest 2005-12-31
Total assets: 6 of 11 periods available· newest 2005-12-31
liabilities: No compatible figures in this window
Current assets: 6 of 11 periods available· newest 2005-12-31
Current liabilities: 6 of 11 periods available· newest 2005-12-31
Cash and cash equivalents: 7 of 11 periods available· newest 2005-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+154.5%

Prior period

USD 2.99 million

2004-01-01 – 2004-12-31
Current period

USD 7.6 million

2005-01-01 – 2005-12-31

Exact inputs and evidence

7603000 − 2988000 = 4615000 USD

2988000 USD · 2004-01-01 – 2004-12-31
Inspect prior input Prior source
7603000 USD · 2005-01-01 – 2005-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · PRAECIS PHARMACEUTICALS INC · 2005-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Year-over-year change in Revenue: 4615000 USD Concept: fundies:Revenue Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 7603000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001104659-06-017625.txt#8964 Input fundies:Revenue: 2988000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001104659-06-017625.txt#8964
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 3.59 million

Prior period

−USD 57.6 million

2004-01-01 – 2004-12-31
Current period

−USD 61.18 million

2005-01-01 – 2005-12-31

Exact inputs and evidence

-61183000 − -57598000 = -3585000 USD

-57598000 USD · 2004-01-01 – 2004-12-31
Inspect prior input Prior source
-61183000 USD · 2005-01-01 – 2005-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · PRAECIS PHARMACEUTICALS INC · 2005-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Year-over-year change in Net income: -3585000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -61183000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001104659-06-017625.txt#10881 Input fundies:NetIncome: -57598000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001104659-06-017625.txt#10881
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 20.56 million

Prior period

−USD 58.02 million

2004-01-01 – 2004-12-31
Current period

−USD 37.46 million

2005-01-01 – 2005-12-31

Exact inputs and evidence

-37458000 − -58018000 = 20560000 USD

-58018000 USD · 2004-01-01 – 2004-12-31
Inspect prior input Prior source
-37458000 USD · 2005-01-01 – 2005-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · PRAECIS PHARMACEUTICALS INC · 2005-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Year-over-year change in Operating cash flow: 20560000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -37458000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001104659-06-017625.txt#11310 Input fundies:OperatingCashFlow: -58018000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001104659-06-017625.txt#11310
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+6.6%

Prior period

USD 1.31 million

2004-01-01 – 2004-12-31
Current period

USD 1.4 million

2005-01-01 – 2005-12-31

Exact inputs and evidence

1395000 − 1309000 = 86000 USD

1309000 USD · 2004-01-01 – 2004-12-31
Inspect prior input Prior source
1395000 USD · 2005-01-01 – 2005-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · PRAECIS PHARMACEUTICALS INC · 2005-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Year-over-year change in Capital expenditure: 86000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 1395000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001104659-06-017625.txt#11445 Input fundies:CapitalExpenditure: 1309000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001104659-06-017625.txt#11445
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2005 2005-01-01 – 2005-12-31

Revenue USD 7.6 million 100% of revenue
Operating costs Derived USD 70.18 million 923% of revenue
Operating income −USD 62.58 million −823% of revenue
Tax, interest and other Derived −USD 1.4 million −18% of revenue
Net income −USD 61.18 million −805% of revenue

Cash

Operating cash flow −USD 37.46 million −493% of revenue
Capital expenditure USD 1.4 million 18% of revenue
Free cash flow Derived −USD 38.85 million −511% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1998 Net income was higher than operating income, so the split is not drawn.
1999 Net income was higher than operating income, so the split is not drawn.
2000 Operating loss: operating costs were 160% of revenue.
2002 Operating loss: operating costs were 6,598% of revenue.
2003 Not shown: operating income or net income is not reported.
2004 Operating loss: operating costs were 2,031% of revenue.
2005 Operating loss: operating costs were 923% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1998 1998-01-01 – 1998-12-31	39567000	37309000 Derived	2258000	-3416000 Derived	5674000	7737000 Derived	Source 1998-01-01 – 1998-12-31: 39567000 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: 2258000 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: 5674000 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: 9229000 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 1492000 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	61514000	54937000 Derived	6577000	-2673000 Derived	9250000	9324000 Derived	Source 1999-01-01 – 1999-12-31: 61514000 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: 6577000 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: 9250000 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: 12880000 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 3556000 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	61189000	97644000 Derived	-36455000	-7719000 Derived	-28736000	-72478000 Derived	Source 2000-01-01 – 2000-12-31: 61189000 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -36455000 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -28736000 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -19955000 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 52523000 USD Inspect Capital Expenditure Open source
2002 2002-01-01 – 2002-12-31	1029000	67896000 Derived	-66867000	-20792000 Derived	-46075000	-71635000 Derived	Source 2002-01-01 – 2002-12-31: 1029000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: -66867000 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -46075000 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: -69879000 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 1756000 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	0	57147000 Derived	-57147000	-1349000 Derived	-55798000	-51891000 Derived	Source 2003-01-01 – 2003-12-31: 0 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -57147000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -55798000 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -50879000 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 1012000 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	2988000	60691000 Derived	-57703000	-105000 Derived	-57598000	-59327000 Derived	Source 2004-01-01 – 2004-12-31: 2988000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -57703000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -57598000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -58018000 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 1309000 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	7603000	70183000 Derived	-62580000	-1397000 Derived	-61183000	-38853000 Derived	Source 2005-01-01 – 2005-12-31: 7603000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -62580000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -61183000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -37458000 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 1395000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 7.6M 2005

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-12-31	Revenue	39567000	Revenue: 39567000 Open source
19991999-12-31	Revenue	61514000	Revenue: 61514000 Open source
20002000-12-31	Revenue	61189000	Revenue: 61189000 Open source
20022002-12-31	Revenue	1029000	Revenue: 1029000 Open source
20032003-12-31	Revenue	0	Revenue: 0 Open source
20042004-12-31	Revenue	2988000	Revenue: 2988000 Open source
20052005-12-31	Revenue	7603000	Revenue: 7603000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

154.5% 2005

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19981998-12-31	Year over year	No prior comparable period	Revenue: 39567000 Open source
19991999-12-31	Year over year	55.5%	Revenue: 61514000 Open source Revenue: 39567000 Open source
20002000-12-31	Year over year	-0.5%	Revenue: 61189000 Open source Revenue: 61514000 Open source
20022002-12-31	Year over year	No prior comparable period	Revenue: 1029000 Open source
20032003-12-31	Year over year	-100%	Revenue: 0 Open source Revenue: 1029000 Open source
20042004-12-31	Year over year	No prior comparable period	Revenue: 2988000 Open source Revenue: 0 Open source
20052005-12-31	Year over year	154.5%	Revenue: 7603000 Open source Revenue: 2988000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -823.1% 2005

Net margin -804.7% 2005

Free cash flow margin -511% 2005

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19981998-12-31	Operating margin	5.7%	Operating Income: 2258000 Open source Revenue: 39567000 Open source
19991999-12-31	Operating margin	10.7%	Operating Income: 6577000 Open source Revenue: 61514000 Open source
20002000-12-31	Operating margin	-59.6%	Operating Income: -36455000 Open source Revenue: 61189000 Open source
20022002-12-31	Operating margin	-6,498.3%	Operating Income: -66867000 Open source Revenue: 1029000 Open source
20032003-12-31	Operating margin	Not reported	Operating Income: -57147000 Open source Revenue: 0 Open source
20042004-12-31	Operating margin	-1,931.2%	Operating Income: -57703000 Open source Revenue: 2988000 Open source
20052005-12-31	Operating margin	-823.1%	Operating Income: -62580000 Open source Revenue: 7603000 Open source
19981998-12-31	Net margin	14.3%	Net Income: 5674000 Open source Revenue: 39567000 Open source
19991999-12-31	Net margin	15%	Net Income: 9250000 Open source Revenue: 61514000 Open source
20002000-12-31	Net margin	-47%	Net Income: -28736000 Open source Revenue: 61189000 Open source
20022002-12-31	Net margin	-4,477.6%	Net Income: -46075000 Open source Revenue: 1029000 Open source
20032003-12-31	Net margin	Not reported	Net Income: -55798000 Open source Revenue: 0 Open source
20042004-12-31	Net margin	-1,927.6%	Net Income: -57598000 Open source Revenue: 2988000 Open source
20052005-12-31	Net margin	-804.7%	Net Income: -61183000 Open source Revenue: 7603000 Open source
19981998-12-31	Free cash flow margin	19.6%	Revenue: 39567000 Open source Operating Cash Flow: 9229000 Open source Capital Expenditure: 1492000 Open source
19991999-12-31	Free cash flow margin	15.2%	Revenue: 61514000 Open source Operating Cash Flow: 12880000 Open source Capital Expenditure: 3556000 Open source
20002000-12-31	Free cash flow margin	-118.4%	Revenue: 61189000 Open source Operating Cash Flow: -19955000 Open source Capital Expenditure: 52523000 Open source
20022002-12-31	Free cash flow margin	-6,961.6%	Revenue: 1029000 Open source Operating Cash Flow: -69879000 Open source Capital Expenditure: 1756000 Open source
20032003-12-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -50879000 Open source Capital Expenditure: 1012000 Open source
20042004-12-31	Free cash flow margin	-1,985.5%	Revenue: 2988000 Open source Operating Cash Flow: -58018000 Open source Capital Expenditure: 1309000 Open source
20052005-12-31	Free cash flow margin	-511%	Revenue: 7603000 Open source Operating Cash Flow: -37458000 Open source Capital Expenditure: 1395000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -37.5M 2005

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-12-31	Operating cash flow	9229000	Operating Cash Flow: 9229000 Open source
19991999-12-31	Operating cash flow	12880000	Operating Cash Flow: 12880000 Open source
20002000-12-31	Operating cash flow	-19955000	Operating Cash Flow: -19955000 Open source
20022002-12-31	Operating cash flow	-69879000	Operating Cash Flow: -69879000 Open source
20032003-12-31	Operating cash flow	-50879000	Operating Cash Flow: -50879000 Open source
20042004-12-31	Operating cash flow	-58018000	Operating Cash Flow: -58018000 Open source
20052005-12-31	Operating cash flow	-37458000	Operating Cash Flow: -37458000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -38.9M 2005

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-12-31	Free cash flow	7737000	Operating Cash Flow: 9229000 Open source Capital Expenditure: 1492000 Open source
19991999-12-31	Free cash flow	9324000	Operating Cash Flow: 12880000 Open source Capital Expenditure: 3556000 Open source
20002000-12-31	Free cash flow	-72478000	Operating Cash Flow: -19955000 Open source Capital Expenditure: 52523000 Open source
20022002-12-31	Free cash flow	-71635000	Operating Cash Flow: -69879000 Open source Capital Expenditure: 1756000 Open source
20032003-12-31	Free cash flow	-51891000	Operating Cash Flow: -50879000 Open source Capital Expenditure: 1012000 Open source
20042004-12-31	Free cash flow	-59327000	Operating Cash Flow: -58018000 Open source Capital Expenditure: 1309000 Open source
20052005-12-31	Free cash flow	-38853000	Operating Cash Flow: -37458000 Open source Capital Expenditure: 1395000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1998-12-31	Liabilities / assets	Not reported	No source recorded
1999-12-31	Liabilities / assets	Not reported	Total Assets: 140331000 Open source
2000-12-31	Liabilities / assets	Not reported	Total Assets: 195571000 Open source
2002-12-31	Liabilities / assets	Not reported	Total Assets: 268250000 Open source
2003-12-31	Liabilities / assets	Not reported	Total Assets: 212478000 Open source
2004-12-31	Liabilities / assets	Not reported	Total Assets: 154307000 Open source
2005-12-31	Liabilities / assets	Not reported	Total Assets: 69544000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

6.65× 2005

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1998-12-31	Current assets / current liabilities	Not reported	No source recorded
19991999-12-31	Current assets / current liabilities	2.79×	Current Assets: 134288000 Open source Current Liabilities: 48068000 Open source
20002000-12-31	Current assets / current liabilities	5.69×	Current Assets: 140418000 Open source Current Liabilities: 24685000 Open source
20022002-12-31	Current assets / current liabilities	18.91×	Current Assets: 195883000 Open source Current Liabilities: 10360000 Open source
20032003-12-31	Current assets / current liabilities	13.16×	Current Assets: 143918000 Open source Current Liabilities: 10937000 Open source
20042004-12-31	Current assets / current liabilities	9.45×	Current Assets: 85446000 Open source Current Liabilities: 9039000 Open source
20052005-12-31	Current assets / current liabilities	6.65×	Current Assets: 63660000 Open source Current Liabilities: 9579000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1998 1998-01-01 – 1998-12-31	USD 5.67 million Exact value Exact value: 5674000 USD 1998-01-01 – 1998-12-31: 5674000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PRAECIS PHARMACEUTICALS INC · 1998-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Net Income: 5674000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: 5674000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0000912057-01-008683.txt#3473 The citation records this snapshot. The page link may show a newer release later.	USD 9.23 million Exact value Exact value: 9229000 USD 1998-01-01 – 1998-12-31: 9229000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PRAECIS PHARMACEUTICALS INC · 1998-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Operating Cash Flow: 9229000 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 9229000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0000912057-01-008683.txt#3491 The citation records this snapshot. The page link may show a newer release later.	USD 1.49 million Exact value Exact value: 1492000 USD 1998-01-01 – 1998-12-31: 1492000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PRAECIS PHARMACEUTICALS INC · 1998-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Capital Expenditure: 1492000 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1492000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0000912057-01-008683.txt#3494 The citation records this snapshot. The page link may show a newer release later.	USD 7.74 million Calculation and evidence 9229000 − 1492000 USD Exact free cash flow: 7737000 USD 1998-01-01 – 1998-12-31: 9229000 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 1492000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PRAECIS PHARMACEUTICALS INC · 1998-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Free cash flow: 7737000 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 9229000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0000912057-01-008683.txt#3491 Input fundies:CapitalExpenditure: 1492000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0000912057-01-008683.txt#3494 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	USD 9.25 million Exact value Exact value: 9250000 USD 1999-01-01 – 1999-12-31: 9250000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PRAECIS PHARMACEUTICALS INC · 1999-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Net Income: 9250000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: 9250000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0000912057-02-012908.txt#3347 The citation records this snapshot. The page link may show a newer release later.	USD 12.88 million Exact value Exact value: 12880000 USD 1999-01-01 – 1999-12-31: 12880000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PRAECIS PHARMACEUTICALS INC · 1999-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Operating Cash Flow: 12880000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 12880000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0000912057-02-012908.txt#3367 The citation records this snapshot. The page link may show a newer release later.	USD 3.56 million Exact value Exact value: 3556000 USD 1999-01-01 – 1999-12-31: 3556000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PRAECIS PHARMACEUTICALS INC · 1999-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Capital Expenditure: 3556000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3556000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0000912057-02-012908.txt#3374 The citation records this snapshot. The page link may show a newer release later.	USD 9.32 million Calculation and evidence 12880000 − 3556000 USD Exact free cash flow: 9324000 USD 1999-01-01 – 1999-12-31: 12880000 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 3556000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PRAECIS PHARMACEUTICALS INC · 1999-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Free cash flow: 9324000 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 12880000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0000912057-02-012908.txt#3367 Input fundies:CapitalExpenditure: 3556000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0000912057-02-012908.txt#3374 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	−USD 28.74 million Exact value Exact value: -28736000 USD 2000-01-01 – 2000-12-31: -28736000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PRAECIS PHARMACEUTICALS INC · 2000-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Net Income: -28736000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -28736000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001047469-03-009258.txt#6639 The citation records this snapshot. The page link may show a newer release later.	−USD 19.96 million Exact value Exact value: -19955000 USD 2000-01-01 – 2000-12-31: -19955000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PRAECIS PHARMACEUTICALS INC · 2000-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Operating Cash Flow: -19955000 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -19955000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001047469-03-009258.txt#6924 The citation records this snapshot. The page link may show a newer release later.	USD 52.52 million Exact value Exact value: 52523000 USD 2000-01-01 – 2000-12-31: 52523000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PRAECIS PHARMACEUTICALS INC · 2000-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Capital Expenditure: 52523000 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 52523000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001047469-03-009258.txt#6989 The citation records this snapshot. The page link may show a newer release later.	−USD 72.48 million Calculation and evidence -19955000 − 52523000 USD Exact free cash flow: -72478000 USD 2000-01-01 – 2000-12-31: -19955000 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 52523000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PRAECIS PHARMACEUTICALS INC · 2000-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Free cash flow: -72478000 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -19955000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001047469-03-009258.txt#6924 Input fundies:CapitalExpenditure: 52523000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001047469-03-009258.txt#6989 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	−USD 54.6 million Exact value Exact value: -54603000 USD 2001-01-01 – 2001-12-31: -54603000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PRAECIS PHARMACEUTICALS INC · 2001-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Net Income: -54603000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -54603000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001104659-04-013235.txt#6621 The citation records this snapshot. The page link may show a newer release later.	−USD 31.64 million Exact value Exact value: -31644000 USD 2001-01-01 – 2001-12-31: -31644000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PRAECIS PHARMACEUTICALS INC · 2001-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Operating Cash Flow: -31644000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -31644000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001104659-04-013235.txt#7050 The citation records this snapshot. The page link may show a newer release later.	USD 23.88 million Exact value Exact value: 23879000 USD 2001-01-01 – 2001-12-31: 23879000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PRAECIS PHARMACEUTICALS INC · 2001-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Capital Expenditure: 23879000 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 23879000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001104659-04-013235.txt#7182 The citation records this snapshot. The page link may show a newer release later.	−USD 55.52 million Calculation and evidence -31644000 − 23879000 USD Exact free cash flow: -55523000 USD 2001-01-01 – 2001-12-31: -31644000 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 23879000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PRAECIS PHARMACEUTICALS INC · 2001-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Free cash flow: -55523000 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -31644000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001104659-04-013235.txt#7050 Input fundies:CapitalExpenditure: 23879000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001104659-04-013235.txt#7182 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	−USD 46.08 million Exact value Exact value: -46075000 USD 2002-01-01 – 2002-12-31: -46075000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PRAECIS PHARMACEUTICALS INC · 2002-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Net Income: -46075000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -46075000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001047469-05-006597.txt#6281 The citation records this snapshot. The page link may show a newer release later.	−USD 69.88 million Exact value Exact value: -69879000 USD 2002-01-01 – 2002-12-31: -69879000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PRAECIS PHARMACEUTICALS INC · 2002-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Operating Cash Flow: -69879000 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -69879000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001047469-05-006597.txt#6478 The citation records this snapshot. The page link may show a newer release later.	USD 1.76 million Exact value Exact value: 1756000 USD 2002-01-01 – 2002-12-31: 1756000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PRAECIS PHARMACEUTICALS INC · 2002-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Capital Expenditure: 1756000 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1756000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001047469-05-006597.txt#6550 The citation records this snapshot. The page link may show a newer release later.	−USD 71.64 million Calculation and evidence -69879000 − 1756000 USD Exact free cash flow: -71635000 USD 2002-01-01 – 2002-12-31: -69879000 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 1756000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PRAECIS PHARMACEUTICALS INC · 2002-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Free cash flow: -71635000 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -69879000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001047469-05-006597.txt#6478 Input fundies:CapitalExpenditure: 1756000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001047469-05-006597.txt#6550 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	−USD 55.8 million Exact value Exact value: -55798000 USD 2003-01-01 – 2003-12-31: -55798000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PRAECIS PHARMACEUTICALS INC · 2003-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Net Income: -55798000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -55798000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001104659-06-017625.txt#10881 The citation records this snapshot. The page link may show a newer release later.	−USD 50.88 million Exact value Exact value: -50879000 USD 2003-01-01 – 2003-12-31: -50879000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PRAECIS PHARMACEUTICALS INC · 2003-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Operating Cash Flow: -50879000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -50879000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001104659-06-017625.txt#11310 The citation records this snapshot. The page link may show a newer release later.	USD 1.01 million Exact value Exact value: 1012000 USD 2003-01-01 – 2003-12-31: 1012000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PRAECIS PHARMACEUTICALS INC · 2003-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Capital Expenditure: 1012000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1012000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001104659-06-017625.txt#11445 The citation records this snapshot. The page link may show a newer release later.	−USD 51.89 million Calculation and evidence -50879000 − 1012000 USD Exact free cash flow: -51891000 USD 2003-01-01 – 2003-12-31: -50879000 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 1012000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PRAECIS PHARMACEUTICALS INC · 2003-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Free cash flow: -51891000 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -50879000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001104659-06-017625.txt#11310 Input fundies:CapitalExpenditure: 1012000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001104659-06-017625.txt#11445 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 57.6 million Exact value Exact value: -57598000 USD 2004-01-01 – 2004-12-31: -57598000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PRAECIS PHARMACEUTICALS INC · 2004-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Net Income: -57598000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -57598000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001104659-06-017625.txt#10881 The citation records this snapshot. The page link may show a newer release later.	−USD 58.02 million Exact value Exact value: -58018000 USD 2004-01-01 – 2004-12-31: -58018000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PRAECIS PHARMACEUTICALS INC · 2004-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Operating Cash Flow: -58018000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -58018000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001104659-06-017625.txt#11310 The citation records this snapshot. The page link may show a newer release later.	USD 1.31 million Exact value Exact value: 1309000 USD 2004-01-01 – 2004-12-31: 1309000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PRAECIS PHARMACEUTICALS INC · 2004-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Capital Expenditure: 1309000 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1309000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001104659-06-017625.txt#11445 The citation records this snapshot. The page link may show a newer release later.	−USD 59.33 million Calculation and evidence -58018000 − 1309000 USD Exact free cash flow: -59327000 USD 2004-01-01 – 2004-12-31: -58018000 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 1309000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PRAECIS PHARMACEUTICALS INC · 2004-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Free cash flow: -59327000 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -58018000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001104659-06-017625.txt#11310 Input fundies:CapitalExpenditure: 1309000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001104659-06-017625.txt#11445 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 61.18 million Exact value Exact value: -61183000 USD 2005-01-01 – 2005-12-31: -61183000 USD Inspect Net Income Open source Share or cite Citation for Net Income · PRAECIS PHARMACEUTICALS INC · 2005-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Net Income: -61183000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -61183000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001104659-06-017625.txt#10881 The citation records this snapshot. The page link may show a newer release later.	−USD 37.46 million Exact value Exact value: -37458000 USD 2005-01-01 – 2005-12-31: -37458000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PRAECIS PHARMACEUTICALS INC · 2005-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Operating Cash Flow: -37458000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -37458000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001104659-06-017625.txt#11310 The citation records this snapshot. The page link may show a newer release later.	USD 1.4 million Exact value Exact value: 1395000 USD 2005-01-01 – 2005-12-31: 1395000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PRAECIS PHARMACEUTICALS INC · 2005-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Capital Expenditure: 1395000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1395000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001104659-06-017625.txt#11445 The citation records this snapshot. The page link may show a newer release later.	−USD 38.85 million Calculation and evidence -37458000 − 1395000 USD Exact free cash flow: -38853000 USD 2005-01-01 – 2005-12-31: -37458000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 1395000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PRAECIS PHARMACEUTICALS INC · 2005-12-31 PRAECIS PHARMACEUTICALS INC (edgar:1033025) Free cash flow: -38853000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T23:15:23Z Snapshot: 913cbd83cd218e4e8bd06d80b237750247ba0058df259456e43d2aa2b5f864f5 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1033025?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -37458000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001104659-06-017625.txt#11310 Input fundies:CapitalExpenditure: 1395000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1033025/0001104659-06-017625.txt#11445 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

36 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001033025, 1033025, edgar:1033025

PRAECIS PHARMACEUTICALS INC

Latest quarter

Revenue

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2005 2005-01-01 – 2005-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation